JP2004536568A5 - - Google Patents

Download PDF

Info

Publication number
JP2004536568A5
JP2004536568A5 JP2002564544A JP2002564544A JP2004536568A5 JP 2004536568 A5 JP2004536568 A5 JP 2004536568A5 JP 2002564544 A JP2002564544 A JP 2002564544A JP 2002564544 A JP2002564544 A JP 2002564544A JP 2004536568 A5 JP2004536568 A5 JP 2004536568A5
Authority
JP
Japan
Prior art keywords
monoclonal antibody
cell line
produce
pta
cell lines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002564544A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004536568A (ja
JP4489351B2 (ja
Filing date
Publication date
Priority claimed from US09/731,126 external-priority patent/US6818392B2/en
Application filed filed Critical
Publication of JP2004536568A publication Critical patent/JP2004536568A/ja
Publication of JP2004536568A5 publication Critical patent/JP2004536568A5/ja
Application granted granted Critical
Publication of JP4489351B2 publication Critical patent/JP4489351B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002564544A 2000-12-06 2001-12-05 ヒト免疫不全ウイルスに対するモノクローナル抗体およびその用途 Expired - Lifetime JP4489351B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/731,126 US6818392B2 (en) 2000-12-06 2000-12-06 Monoclonal antibodies to human immunodeficiency virus and uses thereof
PCT/US2001/043179 WO2002064615A2 (en) 2000-12-06 2001-12-05 Monoclonal antibodies to human immunodeficiency virus and uses thereof

Publications (3)

Publication Number Publication Date
JP2004536568A JP2004536568A (ja) 2004-12-09
JP2004536568A5 true JP2004536568A5 (https=) 2009-01-15
JP4489351B2 JP4489351B2 (ja) 2010-06-23

Family

ID=24938175

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002564544A Expired - Lifetime JP4489351B2 (ja) 2000-12-06 2001-12-05 ヒト免疫不全ウイルスに対するモノクローナル抗体およびその用途

Country Status (6)

Country Link
US (10) US6818392B2 (https=)
EP (2) EP2336175B1 (https=)
JP (1) JP4489351B2 (https=)
CA (1) CA2431321C (https=)
ES (1) ES2619370T3 (https=)
WO (1) WO2002064615A2 (https=)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
US20050054118A1 (en) * 2002-02-27 2005-03-10 Lebrun Stewart J. High throughput screening method
WO2003072752A2 (en) * 2002-02-27 2003-09-04 Miragene, Inc. Improved substrate chemistry for protein immobilization on a rigid support
US8101431B2 (en) 2004-02-27 2012-01-24 Board Of Regents, The University Of Texas System Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems
US8105849B2 (en) 2004-02-27 2012-01-31 Board Of Regents, The University Of Texas System Integration of fluids and reagents into self-contained cartridges containing sensor elements
WO2007053186A2 (en) 2005-05-31 2007-05-10 Labnow, Inc. Methods and compositions related to determination and use of white blood cell counts
WO2008059553A1 (en) * 2006-11-13 2008-05-22 Masami Moriyama Method for detecting hiv-1 without being affected by anti-mouse protein antibody existing in human and kit to be used for the same
FI120376B (fi) * 2007-01-17 2009-09-30 Next Biomed Technologies Nbt O Menetelmä biomuokatun, korkean affiniteetin polypeptidin valmistamiseksi
US20090181359A1 (en) 2007-10-25 2009-07-16 Lou Sheng C Method of performing ultra-sensitive immunoassays
US8222048B2 (en) 2007-11-05 2012-07-17 Abbott Laboratories Automated analyzer for clinical laboratory
SG190572A1 (en) 2008-04-29 2013-06-28 Abbott Lab Dual variable domain immunoglobulins and uses thereof
TW201006485A (en) 2008-06-03 2010-02-16 Abbott Lab Dual variable domain immunoglobulins and uses thereof
CA2726087A1 (en) 2008-06-03 2009-12-10 Tariq Ghayur Dual variable domain immunoglobulins and uses thereof
CN102149825B (zh) 2008-07-08 2015-07-22 Abbvie公司 前列腺素e2双重可变结构域免疫球蛋白及其用途
EP2335069A4 (en) * 2008-09-25 2012-08-01 Univ Duke METHOD FOR DETECTING ANTIBODIES AND ANTIBODY HIV VIRON COMPLEXES
US8916154B2 (en) 2009-04-27 2014-12-23 Abbott Laboratories Antibodies against delta-5 desaturase and uses thereof
US20110008766A1 (en) * 2009-05-01 2011-01-13 Abbott Laboratories Dual Variable Domain Immunoglobulins and Uses Thereof
US20100297778A1 (en) * 2009-05-20 2010-11-25 Abbott Laboratories Conjugate Having Cleavable Linking Agent
EP2478364B1 (en) 2009-09-15 2017-08-02 Gemini Research Limited Detection of auto-antibodies to nuclear antigens
BR112012008833A2 (pt) * 2009-10-15 2015-09-08 Abbott Lab imunoglobulinas de dominio variavel duplo e usos das mesmas
UY32979A (es) 2009-10-28 2011-02-28 Abbott Lab Inmunoglobulinas con dominio variable dual y usos de las mismas
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
EP3252072A3 (en) 2010-08-03 2018-03-14 AbbVie Inc. Dual variable domain immunoglobulins and uses thereof
ES2678145T3 (es) * 2010-08-24 2018-08-09 Abbott Laboratories Anticuerpos específicos contra la proteína del núcleo del VIH y usos de los mismos
JP2013539364A (ja) 2010-08-26 2013-10-24 アッヴィ・インコーポレイテッド 二重可変ドメイン免疫グロブリンおよびその使用
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
US20130064811A1 (en) * 2011-09-09 2013-03-14 International Business Machines Corporation Methods to Enhance Cancer Treatment
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
TW201333035A (zh) 2011-12-30 2013-08-16 Abbvie Inc 針對ｉｌ－１３及／或ｉｌ－１７之雙特異性結合蛋白
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
TW202037609A (zh) 2012-11-01 2020-10-16 美商艾伯維有限公司 抗-vegf/dll4雙重可變區域免疫球蛋白及其用途
WO2014144280A2 (en) 2013-03-15 2014-09-18 Abbvie Inc. DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1β AND / OR IL-17
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10093733B2 (en) 2014-12-11 2018-10-09 Abbvie Inc. LRP-8 binding dual variable domain immunoglobulin proteins
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
TW201710286A (zh) 2015-06-15 2017-03-16 艾伯維有限公司 抗ｖｅｇｆ、ｐｄｇｆ及／或其受體之結合蛋白
CN105929157A (zh) * 2016-05-25 2016-09-07 苏州新波生物技术有限公司 一种联合检测hiv抗原抗体的诊断试剂盒及其制备方法
US20200209226A1 (en) * 2017-01-20 2020-07-02 Shenzhen New Industries Biomedical Engineering Co. Labeled complex, preparation method thereof, kit containing the same, application of kit and detection system comprising kit
CN119264211A (zh) 2018-08-27 2025-01-07 瑞泽恩制药公司 拉曼光谱在下游纯化中的应用
JP7810694B2 (ja) * 2020-07-13 2026-02-03 グリフォルス ダイアグノステック ソリューションズ インコーポレーテッド 抗ヒト免疫不全ウイルス－１抗体及びその使用方法
CN119390828A (zh) * 2024-12-31 2025-02-07 天津龙晟生物科技有限公司 人类免疫缺陷病毒hiv抗体及其应用和其检测产品

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3006207C2 (de) 1980-02-15 1982-10-21 Siemens AG, 1000 Berlin und 8000 München Elektrische Maschine mit einem Ständerblechpaket aus kornorientierten Blechen
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
DE3445816C1 (de) 1984-12-15 1986-06-12 Behringwerke Ag, 3550 Marburg Flaechenfoermiges diagnostisches Mittel
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
NZ220200A (en) 1986-05-19 1990-08-28 Viral Technologies Inc Hiv related peptides, antibodies to the peptides and vaccines therefrom
DE3636540A1 (de) 1986-10-27 1988-04-28 Behringwerke Ag Verfahren zur bestimmung von anti-hiv, mittel dazu und ihre verwendung in diesem verfahren
DE3705686C2 (de) * 1987-02-23 1995-11-30 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Antikörpern
US5104790A (en) 1987-06-29 1992-04-14 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US4886742A (en) 1987-06-15 1989-12-12 Coulter Corporation Enzyme immunoassay for detecting HIV antigens in human sera
US4888290A (en) 1987-11-06 1989-12-19 Coulter Corporation Monoclonal antibody specific to HIV antigens
DE3819079A1 (de) 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
DE3853422T2 (de) 1988-06-09 1995-10-26 Innogenetics Nv HIV-3-Retrovirus und seine Verwendung.
US5173399A (en) 1988-06-10 1992-12-22 Abbott Laboratories Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests
CA1335880C (en) * 1988-07-14 1995-06-13 Thomas P. O'connor Detection of an antibody and antigen in an immunoassay
US5731189A (en) 1989-02-28 1998-03-24 New York University Human monoclonal antibodies to human immunodeficiency virus
ES2094124T3 (es) 1989-03-09 1997-01-16 Abbott Lab Ensayo-inmunologico de anticuerpos contra hiv.
ZA903492B (en) 1989-05-15 1991-02-27 Akzo Nv T-lymphotropic retrovirus monoclonal antibodies
US5210181A (en) * 1989-05-15 1993-05-11 Akzo N.V. T-lymphotropic retrovirus peptide
JPH0831392B2 (ja) * 1990-04-26 1996-03-27 株式会社村田製作所 積層コンデンサ
DE4039925A1 (de) 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
EP0519866A1 (en) 1991-06-18 1992-12-23 Ciba-Geigy Ag Novel anti-HIV antibodies
JP2001504572A (ja) 1992-04-09 2001-04-03 アボツト・ラボラトリーズ Ｈｉｖ抗原及びｈｉｖ抗体を検出するためのアッセイ
DE4236189A1 (de) 1992-10-27 1994-04-28 Boehringer Mannheim Gmbh Verfahren zur simultanen Bestimmung von Antigenen und Antikörpern
EP0627625A1 (en) 1993-06-04 1994-12-07 Abbott Laboratories Immunoassay for differential diagnosis
US5611253A (en) * 1993-09-07 1997-03-18 Tohoku Ricoh Co., Ltd. Cutting device
CA2161872A1 (en) 1994-03-02 1995-09-08 James L. Gallarda Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents
DE59511054D1 (de) 1994-07-25 2006-08-10 Roche Diagnostics Gmbh Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene
CN1114106C (zh) 1994-07-25 2003-07-09 罗切诊断学有限公司 金属螯合物标记的肽及其制备方法
ATE214073T1 (de) 1994-07-25 2002-03-15 Roche Diagnostics Gmbh Hapten-markierte peptide
ATE374253T1 (de) 1994-10-20 2007-10-15 Pasteur Institut Nukleotiden-sequenzen aus retroviren-antigenen hiv-i gruppe (oder untergruppe) o
US6015662A (en) 1996-01-23 2000-01-18 Abbott Laboratories Reagents for use as calibrators and controls
ATE228248T1 (de) * 1997-03-10 2002-12-15 Roche Diagnostics Gmbh Verfahren zur simultanen bestimmung von hiv- antigenen und hiv-antikörpern
DE19727943A1 (de) 1997-03-10 1998-09-24 Boehringer Mannheim Gmbh Verfahren zur simultanen Bestimmung von HIV-Antigenen und HIV-Antikörpern
US6495599B2 (en) 2000-04-13 2002-12-17 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses therof
US6818392B2 (en) * 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
ES2678145T3 (es) * 2010-08-24 2018-08-09 Abbott Laboratories Anticuerpos específicos contra la proteína del núcleo del VIH y usos de los mismos

Similar Documents

Publication Publication Date Title
JP2004536568A5 (https=)
JP2004504063A5 (https=)
JP2004531270A5 (https=)
JP2004502409A5 (https=)
NZ616992A (en) Anti-ilt7 antibody
JP2004527212A5 (https=)
NZ547157A (en) Interferon Alpha Antibodies and their uses
JP2005516606A5 (https=)
ATE208820T1 (de) Humanisierte antikoerper
EP2426146A3 (en) Anti-human IL-21 monoclonal antibodies
UA94060C2 (ru) Моноклональное антитело, которое специфически связывает alk-1
DE69527975D1 (de) Humanisierte antikörper gegen cd38
WO2002022851A3 (en) Novel tumor-associated marker
MY126251A (en) In-situ balancing for phase-shifting mask.
EP2277920A3 (en) Inhibitors of complement activation
EP1881064A3 (en) HCV-Anti-core monoclonal antibodies
JP2008511291A5 (https=)
JP2004500320A5 (https=)
NZ621483A (en) Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r
CA2221893A1 (fr) Anticorps specifique de staphylococcus aureus et utilisations
ES2484340T3 (es) Anticuerpos anti hsp70 terapéuticos y diagnósticos
EP1144006A4 (en) SYNERGISTIC INHIBITION OF HIV-1 FUSION AND BINDING AND COMPOSITION AND ANTIBODIES RELATING thereto
AU7960600A (en) Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit
WO2002062972A3 (en) Hybridoma cell line g250 and its use for producing monoclonal antibodies
CA2080548A1 (en) Monoclonal antibodies to hepatitis c virus